The outcome is binary after the reconvened vote on May 29. Approval would reduce option strike prices to market, potentially dilutive if currently out-of-the-money options become exercisable, but also removes potential overhang of underwater options. Rejection leaves the current option structure unchanged. Monitor the May 29 closing price and the vote result for near-term impact.
Price Chart
Executive Summary
Coherus Oncology's 2026 annual meeting was adjourned from May 27 to May 29, 2026, to count remaining votes on Proposal No. 4 — a stock option repricing that would set the exercise price of certain outstanding options to the May 29 closing price and extend terms by 10 years. Approval requires a majority of votes cast (excluding abstentions and broker non-votes). Voting on the other four proposals was completed.
Key Facts
- Annual meeting adjourned from May 27 to May 29, 2026 at 3:00 PM PT to finish counting votes on Proposal No. 4.
- Proposal No. 4 would reprice eligible options to May 29 closing price and extend term 10 years from May 29, 2026.
- If options are exercised or holder terminates service before May 29, 2027, the exercise price reverts to the original price.
- Quorum was present; votes on Proposals 1, 2, 3, and 5 were completed at the original meeting.
- Proposal No. 4 requires majority of votes cast for approval (abstentions and broker non-votes excluded).
Financial Impact
Stock option repricing to then-current closing price — dollar value depends on May 29 close and number of eligible options; no figures provided.
Risk Factors
- Approval could signal management retention but also implies shareholder willingness to reprice — may set precedent for future repricings.
- No specific share counts or option details disclosed; materiality of repricing cannot be assessed from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-067154 |
| Document: 0001104659-26-067154-index-headers.html | 0001104659-26-067154 |
| Document: 0001104659-26-067154-index.html | 0001104659-26-067154 |
| Document: 0001104659-26-067154.txt | 0001104659-26-067154 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Press Release | $1.34 $1.29 | ▼ −4.10% | ▼ −3.11% | $1.16 (−13.43%) |
Jul 22, 2026 10w ago | Press Release | $1.43 $1.33 | ▼ −6.99% | ▼ −9.89% | $1.16 (−18.88%) |
Jun 15, 2026 15w ago | 8-K | $1.38 $1.45 | ▲ +5.07% | ▲ +4.87% | $1.16 (−15.94%) |
Jun 12, 2026 16w ago | Institutional Cluster | $1.40 $1.54 | ▼ −10.00% | ▼ −8.22% | $1.16 (+17.14%) |
May 28, 2026 18w ago | DEFA14A | $1.65 $1.50 | ▼ −9.09% | ▼ −5.95% | $1.16 (−29.70%) |
May 11, 2026 20w ago | Press Release | $1.71 $1.36 | ▼ −20.47% | ▼ −18.74% | $1.16 (−32.16%) |
May 5, 2026 21w ago | DEFA14A | $1.75 $1.47 | ▼ −16.00% | ▼ −18.78% | $1.16 (−33.71%) |
May 4, 2026 21w ago | Press Release | $1.73 $1.57 | ▼ −9.25% | ▼ −14.89% | $1.16 (−32.95%) |
Mar 9, 2026 29w ago | Press Release | $1.95 $1.70 | ▼ −12.82% | ▼ −12.67% | $1.16 (−40.51%) |
Mar 2, 2026 30w ago | Press Release | $1.65 $1.60 | ▼ −3.03% | ▲ +4.91% | $1.16 (−29.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access